Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. Of 272 combined patients, 86% experienced some clinical benefit, and 10% experienced a complete clinical response. improvement in good sleep.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

FloridaMarijuana.net

OCTOBER 9, 2018

In 2017, The National Academies of Sciences, Engineering, and Medicine published a statement that the use of cannabis for the treatment of pain is supported by “well-controlled clinical trials and that there is substantial evidence that cannabis is an effective treatment for chronic pain in adults.”.

Terpenes 100

Terpenes Chronic Pain Strains Clinical Trials 100

Cannabis Law Report

AUGUST 14, 2021

Cann Group CEO Peter Crock said of the products: “Satipharm CBD capsules were one of the first medicinal cannabis products available to approved patients in Australia (under the Special Access Scheme) and have been successfully used in a variety of medical conditions since 2017. Shares in Cann Group were up 3.33 per cent to $0.31

CBD 105

CBD Clinical Trials Programs Medicine 105

CannaMD

NOVEMBER 6, 2019

Today, both patient experience and modern scientific research support claims of medical marijuana’s effectiveness for pain management. Questions included any changes in personal levels of opioid use when marijuana was also used, and the reasons why patients were substituting marijuana for prescription pain medications.

Marijuana 107

Marijuana Patients Clinical Trials Data 107

Cannabis Law Report

JULY 7, 2021

The country, which Tilray said has an estimated medical marijuana demand of more than 100,000 patients, legalized the drug for medical use in 2017 but has since relied on importing it. What they’re asking is … for information,” she said, like how the products are used, how patients can be instructed, and what dosage is. “We

Clinical Trials 81

Clinical Trials Education Data Pharmaceutical 81

Cannabis Law Report

JULY 28, 2021

However, prior to committing to a substantial clinical program for that indication, PharmaDrug looked to further expand on the body of existing supportive data for esophageal cancer, while also potentially revealing new, promising cancer indications. ” Next Steps. Cepharanthine’s Rationale in Cancer. dcohen@pharmadrug.co.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Canna Law Blog

MARCH 4, 2020

Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine.

Therapy 102

Therapy Legalization Chronic Pain DEA 102

The Cannigma

AUGUST 31, 2021

The researchers stated that these knowledge gaps must be addressed and that “clinical trial data about how medical cannabis improves patient quality of life domains is desperately needed as this information can impact clinical decision-making.”. The researchers did note however that only 2.9%

Education 101

Education Clinical Trials Medicine Policy 101

The Joint Blog

JUNE 2, 2020

According to a new study published in the European Journal of Pain, delivering a precise doses of THC via a specialized inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions. 9 -Tetrahydrocannabinol (THC) in patients with chronic pain. 9 -THC: 0.5mg, 1mg, or a placebo. ?

Chronic Pain 58

Chronic Pain Clinical Trials Marijuana Safety 58

Healer

MARCH 26, 2021

Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. I never thought that would have been possible,” he said. Every day is different, (but) at this point I’m at least present,” he said.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

JULY 9, 2021

Patients would participate in therapy sessions to prepare for the use of psychedelics, after which the substances would be administered under the guidance and supervision of trained medical professionals. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].

Law 81

Law Therapy Clinical Trials Research and Development 81

Greencamp

FEBRUARY 2, 2019

Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. Cannabis as a palliative aid for HIV patients. What is HIV and how is it manifested? How classical pharmaceuticals fight HIV. 2016 ( 3 ).

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Canna Care Docs

DECEMBER 11, 2018

It’s hard to get past decades of federal prohibition and criminalization, so it’s little wonder that in 2017 only three percent of adults over 65 years old reported being “current smokers.” [1]. “Americans Who Smoke Marijuana By Age Group 2017 | Statistic” 2018. Here, too, cannabis has been shown to have a distinct effect.

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

LifeCannMD

AUGUST 2, 2024

More clinical trials are needed to establish definitive efficacy and safety profiles. 2017 Study Published in “Cannabis and Cannabinoid Research” – Findings: This study found that medical cannabis users experienced significant reductions in headache and migraine frequency. .

Clinical Trials 52

Clinical Trials Marijuana Research and Development Cannabinoids 52

Project CBD

FEBRUARY 28, 2023

CBD first appeared on the natural channel’s top 40 list in 2017, ranking 12th, after sales growth of more than 300% from the previous year. million more on CBD products in 2021 compared to 2017 — a 413.4% Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

NOVEMBER 29, 2019

These include the potential to relieve symptoms like nausea and vomiting in cancer patients after undergoing chemotherapy treatment. THC has shown the potential to help with appetite among patients with eating disorders. It also has the potential to help patients with neurodegenerative diseases and relieving pain in cancer patients.

Oil 80

Oil THC Cannabinoids Research and Development 80

Cannabis Law Report

FEBRUARY 2, 2022

The double-blind, randomised, placebo-controlled clinical trial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. As many patients use cannabis-based medicines to aid with sleep, the current detection window is of significant concern.

Medicine 52

Medicine Clinical Trials Consumption Sleep 52

United Patients Group

JANUARY 5, 2023

A 2017 review of 10 clinical trials found that people who took probiotics had a 14% lower risk of contracting a cold or flu. The post 10 Benefits of Probiotics for Your Immune System appeared first on United Patients Group. Probiotics May Reduce Flu Risk. Probiotics may reduce the risk of developing a cold or flu.

Digestion 105

Digestion Research and Development Food Strains 105

Veriheal

JUNE 7, 2021

MDMA has also reportedly been used with over 1,000 individuals in clinical trials , with no adverse effects to report. . The medical professional administering this treatment may give the patient a follow-up half-dose around 2 hours after the first one- although this only happens when deemed necessary. Alcohol Addiction.

Therapy 92

Therapy Treatment Conditions Clinical Trials 92

Cannabis Law Report

FEBRUARY 7, 2020

The study by researchers from the University of Auckland and medical cannabis clinic owner Dr Graham Gulbransen looked at how patients were faring after using cannabidiol (CBD), the non-intoxicating compound in cannabis that has had so much attention these past few years. Neurological symptoms – 15.1%. Cancer symptoms – 23.2%.

Chronic Pain 45

Chronic Pain Clinical Trials Conditions Patients 45

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Patients using warfarin need to have their blood INR level tested after adding THC-containing cannabis to their regimen. topiramate. rufinamide. zonisamide. eslicarbazepine.

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

NOVEMBER 29, 2019

While the market for medical cannabis is already well developed in some EU member states, only EU-wide standards can ensure patients have the same across Europe. Different legislation across EU countries on prescribing cannabis-based medicines can hinder patients’ access to their treatment when they travel abroad, EUMCA said.

Medicine 45

Medicine Clinical Trials Treatment Access 45

Cannabis Info

OCTOBER 11, 2019

One such breakthrough in research came back in 2017, when researchers found strong evidence that cannabis could help treat dementia. Now, clinical studies are about to get underway at an Australia university, to track changes in actual dementia patients to see if cannabis can help. Cannabis research in the U.S.

Treatment 45

Treatment Clinical Trials Cannabinoids Cannabis 45

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. On May 3, 2021, our study of MDMA-assisted therapy for PTSD achieved successful results for patients with severe, chronic PTSD.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

The Joint Blog

FEBRUARY 18, 2020

Marijuana use is associated with a reduction in the use of attention-deficit hyperactivity disorder (ADHD) medications in patients diagnosed with the syndrome, according a new study published in the journal Rambam Maimonides and first reported on by NORML. score, n=30) or high ASRS score (i.e. ?3.18 score, n=29) subgroups.

Clinical Trials 45

Clinical Trials Terpenes Data Cannabinoids 45

Cannabis Law Report

MAY 29, 2019

“The licence enables our strategic alliance with RMIT to advance on its objective to establish a world first library of cannabis medicines, as well as conducting ground-breaking pre-clinical research into the positive effects that medicinal cannabis may have on specific cancers.”.

Cultivation 40

Cultivation Pharmaceutical Clinical Trials Extraction 40

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. Of 272 combined patients, 86% experienced some clinical benefit, and 10% experienced a complete clinical response. improvement in good sleep.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

The Cannigma

MARCH 12, 2021

But sometimes one unintended consequence of adult-use legalization is that the market no longer caters to medical patients. So, you have this attempt to legitimize healthcare and to adopt standards, to do things in a more scientific way, and in a more credible way, for patients and for industry. It’s a non-trivial issue.

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

SEPTEMBER 1, 2019

The Victorian and New South Wales Governments had both begun clinical trials of cannabis products for children with severe epilepsy and for palliative care, respectively. The clinical trials and the standard of production could lead the world.”. Around the country, the nascent industry’s march is gathering pace.

Clinical Trials 53

Clinical Trials Research and Development Medicine Cultivation 53

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. No hepatic side effects were noted.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Green Relief

MAY 13, 2018

A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

DECEMBER 17, 2021

deletion syndrome patient pool and forecasted trend for each seven major countries. This part of The report also provides the diagnosed patient pool and their trends along with assumptions undertaken. deletion syndrome is often underdiagnosed and misdiagnosed, as the symptoms vary from patient to patient.

Clinical Trials 40

Clinical Trials Research and Development Pharmaceutical Therapy 40

CannaMD

AUGUST 26, 2020

World Drug Report ‘s estimation that 18 million people between 15 and 64 years of age consumed cocaine in 2017. Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., mice/rats).

Therapy 98

Therapy CBD Research and Development Treatment 98

Alchimia

FEBRUARY 1, 2022

Adverse effects at the endocrine level : during the period of CBD administration, it has been observed that in some patients this causes an increase in transaminases in the liver. More research and clinical trials on the matter, especially its long-term effects, are still needed. Drowsiness. Reduced appetite/weight changes.

CBD 52

CBD Epilepsy Research and Development Cannabinoids 52

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Patients using warfarin need to have their blood INR level tested after adding THC-containing cannabis to their regimen. topiramate. rufinamide. zonisamide. eslicarbazepine.

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

DECEMBER 7, 2021

A systematic review published in 2017 aimed to identify available data about the therapeutic effect of cannabinoids treatment in children and adolescents. Since various adverse mental events can be interpreted differently by the patients, caregivers and the researchers, a united outcome of adverse mental events was measured.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.

Research and Development 52

Research and Development Medicine Access Media 52